(Total Views: 373)
Posted On: 09/28/2025 5:59:32 PM
Post# of 157348
Can someone help me understand exactly what Dr JL means by this? It s a transcription made by MGK_2 of his interview in August.
[00:30:10]: In the meantime we've started to enroll our Colorectal cancer study have a bunch of sites actively enrolling now and what we're going to be doing shortly is submitting a request to the FDA for a meeting at which point we're going to give them a rollover protocol for the Colorectal cancer patients that we're monitoring their PD-L1 status during the study and in the rollover protocol. We hope to then provide them a checkpoint inhibitor to see if we can replicate that clinical benefit, that survival benefit that we saw in the breast cancer patients.
[00:30:10]: In the meantime we've started to enroll our Colorectal cancer study have a bunch of sites actively enrolling now and what we're going to be doing shortly is submitting a request to the FDA for a meeting at which point we're going to give them a rollover protocol for the Colorectal cancer patients that we're monitoring their PD-L1 status during the study and in the rollover protocol. We hope to then provide them a checkpoint inhibitor to see if we can replicate that clinical benefit, that survival benefit that we saw in the breast cancer patients.
(8)
(0)
